Darcy Parkyn

Darcy Parkyn is a seasoned professional in the oncology marketing field, currently serving as Global Commercial Leader for Breast Cancer Disease Area Strategy and Pipeline at BeiGene since January 2025. Previously, Darcy held positions including Executive Director of Marketing for Breast Cancer Oncology at Stemline Therapeutics, and Head of Global Breast Cancer Marketing at Sanofi. With a robust background in commercial leadership roles at companies such as Puma Biotechnology, BioMarin Pharmaceutical, and Medivation, Darcy has extensive expertise in oncology marketing, product management, and launch strategies. Darcy's educational qualifications include a Master of Public Administration in Healthcare, a Bachelor of Science in Business Communications, and a Master of Public Health, all obtained from the University of San Francisco. Currently seeking new opportunities following the failure of amcenestrant in Phase III trials.